CuraCell Selects IKF as CRO Partner for Its Phase 1/2a Trial

August 22nd, 2023

CuraCell has signed a partnership agreement with the German Clinical Research Organisation, IKF, located in Frankfurt, Germany. IKF will support CuraCell in the preparation of the upcoming phase 1/2a trial and coordinate clinical operations throughout the trial.

IKF is specialized in investigator-initiated and industry-academia collaborative cancer research. Founded by oncologists, with more the 20 years of operations, the company has been involved in oncology trials across 300 centers world-wide.